Results 211 to 220 of about 107,613 (242)
Producing MSCs on rigid culture substrates induces a scar‐making phenotype, jeapordizing therapeutic success. ‘Tissue‐soft’ surfaces prevent MSC fibrogenesis and preserve regenerative traits. An epigenetic network, driven by HOXA11 and SALL1, maintains ‘soft memory’ by keeping chromatin open in relaxed MSCs, promoting anti‐fibrotic programs.
Fereshteh Sadat Younesi +7 more
wiley +1 more source
Consumer sleep technologies that self-screen or self-assess risk for OSA: is subclinical OSA (SCOSA) coming to our clinics? [PDF]
Schutte-Rodin S +3 more
europepmc +1 more source
Lifetime and world-time in accelerated medicine. An essay on the consolation of synchronisation. [PDF]
Wiesing U.
europepmc +1 more source
Updates in Type 1 Diabetes (T1D): What Recent Findings Might Mean for Treatment and Prevention Strategies. [PDF]
Bloomgarden Z.
europepmc +1 more source
Reflections from a departing editor-in-chief. [PDF]
Samet JM.
europepmc +1 more source
Expert perspectives on US regulatory approaches to large language models in healthcare. [PDF]
Gilbert S, Dai T.
europepmc +1 more source

